Represented China SXT Pharmaceuticals, Inc. in $9 Million Registered Direct Offering

Represented China SXT Pharmaceuticals, Inc., an innovative pharmaceutical company focusing on the research, development, manufacture, marketing and sales of traditional Chinese medicine pieces, in its $9 million registered direct offering.